Home Accent Therapeutics

Accent Therapeutics

In operation
Series C
RNA Modification Targeted Drug Developer
Basic
Enterprise Profile

Basic Information

Accent Therapeutics was founded with the mission to develop innovative therapies in the field of epitranscriptomics, which focuses on how RNA structure, stability, function, and translation contribute to the onset of various diseases. The company’s current goal is to develop drugs that target RNA modifications.
Accent Therapeutics, Inc.
Massachusetts,United States of America
15~50 people
January 01, 2017
contactus@accenttx.com

Enterprise Profile

Industrial Sector
New Drug Development Biological Drug Production
Technology
Targeted Technology
Concept
Tumor Therapeutic Products
Application Scenarios
Innovative Drugs